Unity Biotechnology Inc (UBX)

NASDAQ
2.880
+0.030(+1.05%)
  • Volume:
    134,927
  • Day's Range:
    2.800 - 3.030
  • 52 wk Range:
    2.090 - 19.110

UBX Overview

Prev. Close
2.85
Day's Range
2.8-3.03
Revenue
5.02M
Open
2.85
52 wk Range
2.09-19.11
EPS
-7.61
Volume
134,927
Market Cap
41.02M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
690,647
P/E Ratio
-0.313
Beta
0.615
1-Year Change
-85.38%
Shares Outstanding
14,192,305
Next Earnings Date
14 Mar 2023
What is your sentiment on Unity Biotech?
or
Vote to see community's results!

Unity Biotechnology Inc News

Unity Biotechnology Inc Analysis

Unity Biotechnology Inc Company Profile

Unity Biotechnology Inc Company Profile

Employees
65

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company’s lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Read More

Analyst Price Target

Average38.400 (+1,228.720% Upside)
High120.000
Low10.000
Price2.890
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyNeutralStrong Sell
Technical IndicatorsStrong SellStrong SellBuyStrong BuyStrong Sell
SummaryStrong SellSellBuyBuyStrong Sell